Addex Therapeutics Ltd (ADXN)
NCM – Real vaqt narxi. Valyuta: USD
6.70
+0.40 (6.35%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT

NCM – Real vaqt narxi. Valyuta: USD
6.70
+0.40 (6.35%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
Addex Therapeutics Ltd Shveytsariyada nevrologik kasalliklar uchun kichik molekulali farmatsevtika mahsulotlarini kashf qilish, ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya G-protein bilan bog'langan retseptorlar va fermentlarni kashf qilishga qaratilgan. Uning asosiy dasturlari orasida Dipraglurant mavjud bo'lib, u insultdan keyingi/miya jarohatidan tiklanishni davolash uchun, shuningdek, Parkinson kasalligida levodopa bilan bog'liq diskineziyani davolash uchun 1-bosqichli klinik sinovlarda. Kompaniya, shuningdek, ADX71149, yangi og'zaki faol metobotropik glutamat retseptorlari 2-tipi musbat allosterik modulyatori (mGlu2 PAM) ishlab chiqadi; va og'riq, tashvish, giyohvandlik, yo'tal va giperaktiv siydik pufagini davolash uchun GABAB PAM. Kompaniyaning Janssen Pharmaceuticals Inc. bilan inson salomatligini davolash uchun mGlu2 PAM birikmalarini ishlab chiqish bo'yicha litsenziya va hamkorlik shartnomasi mavjud; va Indivior PLC bilan giyohvandlik va boshqa O'NKS kasalliklarini davolash uchun yangi GABAB PAM birikmalarini kashf qilish, ishlab chiqish va tijoratlashtirish bo'yicha litsenziya va tadqiqot shartnomasi. Kompaniya ilgari Addex Pharmaceuticals Ltd nomi bilan tanilgan. Addex Therapeutics Ltd 2002 yilda tashkil etilgan va Jeneva, Shveytsariyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Mikhail Kalinichev Ph.D. | Head of Translational Science |
| Dr. Roger G. Mills M.D. | Chief Medical Officer & Director |
| Mr. Lénaic Teyssédou | Head of Finance |
| Mr. Timothy Mark Dyer | Co-Founder, CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-07 | 6-K | f6k_010726.htm |
| 2025-12-04 | 6-K | tm2532672d1_6k.htm |
| 2025-11-19 | F-3 | tm2531595-1_f3.htm |
| 2025-10-29 | 6-K | f6k_102925.htm |
| 2025-09-30 | 6-K | adxn-20250630x6k.htm |
| 2025-09-23 | 6-K | f6k_092325.htm |
| 2025-06-30 | 6-K | f6k_063025.htm |
| 2025-06-25 | 6-K | f6k_062525.htm |
| 2025-06-20 | 6-K | tm2518303d1_6k.htm |
| 2025-06-06 | 6-K | f6k_060625.htm |